These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6770589)

  • 21. Slow-reacting substance of anaphylaxis: studies on purification and characterisation.
    Morris HR; Taylor GW; Piper PJ; Tippins JR
    Agents Actions Suppl; 1979; (6):27-36. PubMed ID: 43080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of release of slow-reacting substance by arsenic.
    Funderburk WH; Foxwell M; Ward JW
    Eur J Pharmacol; 1969 Jan; 5(2):203-8. PubMed ID: 4181157
    [No Abstract]   [Full Text] [Related]  

  • 23. Slow reacting substance of anaphylaxis (SRS-A): cellular controls of synthesis and biological effects of its constituent leukotrienes.
    Lewis RA; Austen KF
    Prog Lipid Res; 1981; 20():713-8. PubMed ID: 7342125
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of slow-reacting substance in asthma.
    Brocklehurst WE
    Adv Drug Res; 1970; 5():109-13. PubMed ID: 4923800
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukotriene C4: the major lipoxygenase metabolite of arachidonic acid in dog spleen.
    Malik KU; Wong PY
    Biochem Biophys Res Commun; 1981 Nov; 103(2):511-20. PubMed ID: 6800364
    [No Abstract]   [Full Text] [Related]  

  • 26. The partial purification of slow reacting substance of anaphylaxis from rat peritneal anaphylactic fluid and its separation from an arachidonic acid releasing substance.
    Whelan CJ
    Biochem Pharmacol; 1980 Feb; 29(3):319-23. PubMed ID: 7362644
    [No Abstract]   [Full Text] [Related]  

  • 27. C5a-induced tracheal contraction: effect of an SRS-A antagonist and inhibitors of arachidonate metabolism.
    Regal JF; Pickering RJ
    J Immunol; 1981 Jan; 126(1):313-6. PubMed ID: 7451973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further evidence on the structure of slow reacting substance of anaphylaxis (SRS-A).
    Sirois P; Moore EG; Orange RP
    Agents Actions; 1979 Oct; 9(4):337-43. PubMed ID: 117689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular mechanisms involved in the release of slow reacting substance of anaphylaxis.
    Orange RP; Stechschulte DJ; Austen KF
    Fed Proc; 1969; 28(5):1710-5. PubMed ID: 4185891
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-slow reacting substance of anaphylaxis effect of verapamil].
    Zhang HQ; Bian RL
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):110-2. PubMed ID: 2934942
    [No Abstract]   [Full Text] [Related]  

  • 31. Stereochemistry of leukotriene C-1.
    Hammarström S; Samuelsson B; Clark DA; Goto G; Marfat A; Mioskowski C; Corey EJ
    Biochem Biophys Res Commun; 1980 Feb; 92(3):946-53. PubMed ID: 6102463
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of leukotriene C-1 as a major component of slow-reacting substance from rat mononuclear cells.
    Bach MK; Brashler JR; Hammarström S; Samuelsson B
    J Immunol; 1980 Jul; 125(1):115-7. PubMed ID: 6103909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of vasoactive substances from guinea-pig lungs by slow-reacting substance c and arachidonic acid. Its blockade by nonsteroid anti-inflammatory agents.
    Vargaftig BB; Dao N
    Pharmacology; 1971; 6(2):99-108. PubMed ID: 4400351
    [No Abstract]   [Full Text] [Related]  

  • 34. Slow-reacting substances and their formation by a lipoxygenase pathway.
    Piper PJ; Samhoun MN; Tippins JR; Morris HR; Taylor GW
    Agents Actions; 1980 Dec; 10(6):541-7. PubMed ID: 6115549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukotriene C5: a slow reacting substance derived from eicosapentaenoic acid.
    Hammarström S
    J Biol Chem; 1980 Aug; 255(15):7093-4. PubMed ID: 6104669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of eosinophil chemotaxis by the antagonist of slow reacting substance of anaphylaxis--compound FPL 55712.
    Jones DG; Kay AB
    J Pharm Pharmacol; 1974 Nov; 26(11):917-8. PubMed ID: 4156570
    [No Abstract]   [Full Text] [Related]  

  • 37. Isolation and characterization of 15-hydroxylated metabolites of leukotriene C4.
    Orning L; Hammarström S
    FEBS Lett; 1983 Mar; 153(2):253-6. PubMed ID: 6413247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion of 5,8,11-eicosatrienoic acid to leukotrienes C3 and D3.
    Hammarström S
    J Biol Chem; 1981 Mar; 256(5):2275-9. PubMed ID: 6780563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ["Slow reacting substance of anaphylaxis": biochemical characterization and new prospects for the treatment of asthma and other allergic diseases (author's transl)].
    Boeynaems JM; Delespesse G
    Rev Med Brux; 1981 Nov; 2(9):803-9. PubMed ID: 6798664
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of arachidonic acid products in asthma.
    Clay TP; Miller P
    Practitioner; 1984 May; 228(1391):510-3. PubMed ID: 6433339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.